Childhood and adolescent ovarian malignant tumors in Israel A nationwide study

Size: px
Start display at page:

Download "Childhood and adolescent ovarian malignant tumors in Israel A nationwide study"

Transcription

1 Acta Obstet Gynecol Scand 1999; 78: Copyright C Acta Obstet Gynecol Scand 1999 Printed in Denmark All rights reserved Acta Obstetricia et Gynecologica Scandinavica ISSN ORIGINAL ARTICLE Childhood and adolescent ovarian malignant tumors in Israel A nationwide study JOSEPH MENCZER 1, SIEGAL SADETZKI 2, HAVI MURAD 2, GIULIA BARDA 1, HELENA ANDREEV 3 AND MICHA BARCHANA 3 From the 1 Gynecologic Oncology Unit, Department of Obstetrics and Gynecology, Edith Wolfson Medical Center, Holon, the 2 Department of Clinical Epidemiology, Sheba Medical Center, Tel-Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv and the 3 Israel Cancer Registry, Ministry of Health, Jerusalem, Israel Acta Obstet Gynecol Scand 1999; 78: C Acta Obstet Gynecol Scand 1999 Objectives. To determine the incidence of ovarian malignant tumors in childhood and adolescence, to ascertain the frequency distribution of the various tumor types and to assess time trends in Israel on a nationwide basis. Methods. The study group included all Israeli Jewish patients Æ19 years old with histologically confirmed ovarian malignancies, diagnosed in Israel from 1970 to Data were obtained from the Israel Cancer Registry. The effects of age at diagnosis and period of diagnosis were analyzed using the Poisson regression. Results. Among the 82 patients identified, the most frequent tumors (72.0%) were of germ cell origin and among those about one third were dysgerminomas. Epithelial tumors were diagnosed in 26.6% of the patients and most of these were borderline malignancies. The incidence rate (IR) for the total group of ovarian malignancies in the 0 19 age group was 0.52 and for ages 5 19 it was 0.71 per 100,000. After adjustment for age, a significant linear trend for a decrease of germ cell tumors over time was found, stemming from a decrease of dysgerminomas. A significant trend for increase in the IRs with age was also found. In addition, a steep rise in the age specific IRs of epithelial borderline tumors was noted in the last 5 year period. Conclusions. The IRs of ovarian malignancies in childhood and adolescence in Israel, as in other countries, is very low as compared to adults and the most common tumors are of germ cell origin while malignant epithelial tumors are very rare. A time period effect in the germ cell tumors that resulted from an inexplicable significant decrease in the age specific IRs of dysgerminomas, was observed. A significant increase in borderline tumors was also noted and may be attributed to greater awareness of pathologists to this entity. Key words: adolescence; borderline malignancy; childhood; dysgerminoma; ovarian tumors Submitted 23 June, 1998 Accepted 16 April, 1999 Ovarian carcinoma is the most frequent gynecological malignancy among Israeli women and its incidence in 1994 was 13.8/ (1). As in other populations, epithelial neoplasms are the most frequent histological type, while non-epithelial tumors are rare and constitute only about 12% of the total (2). In contrast, in childhood and adoles- Abbreviations: IR: incidence rate; CI: confidence interval. cence the majority of malignant ovarian tumors are non-epithelial and most of them are of germ cell origin. Important advancements with regard to diagnosis, and in the field of pathology and treatment, have been achieved during the last two decades. Many of these tumors produce markers that allow, nowadays, preoperative diagnosis and better follow up monitoring. A grading system of teratomas allows identification of low and high risk groups. With modern cisplatin based combi-

2 814 J. Menczer et al. nation chemotherapy, cure can be achieved and reproductive function preserved in the majority of young patients with non epithelial malignant ovarian tumors (3). It is well known that ovarian malignancies in childhood and adolescence are uncommon but information concerning the true incidence in this group in various populations is scarce. The following are the results of a nationwide population based study of ovarian malignancies in childhood and adolescent patients in Israel. Its purpose was to determine the incidence of ovarian malignant tumors in childhood and adolescence, to ascertain the frequency distribution of the various tumor types in this age group and to assess these trends over time. Material and methods The study group included all Jewish patients Æ19 years old, with histologically confirmed ovarian malignancies diagnosed in Israel during the 25 year period from 1970 to Data were obtained from the Israel Cancer Registry that by law is notified of all new cancer patients. The pathologic categorization of histologic subtypes is based on the World Health Organization classification (4) according to the original pathology report and additional data on hospital discharge summaries, when available. For the purpose of analysis, the total study period was divided into five-year periods. The incidence rates (IRs) of the tumors were calculated for Table I. Distribution of patients according to detailed hystologic type No. % Hystologic type Germ cell tumors Dysgerminoma Immature Teratoma ª ª Mixed germ cell Endodermal sinus Undefined Sex-cord stromal Granulosa cell Sertoli Leydig cell Epithelial Serous Borderline Invasive Mucinous Borderline Invasive Small cell Total the five designated periods and three age group categories. Age-specific IRs as well as total IRs for all ages combined were computed using the number of new patients in the appropriate combinations of age group and period as the nominator and the respective populations as denominator. These denominators were taken from the Statistical Abstract of Israel of the appropriate years. The effects of age at diagnosis and periods of diagnosis were analyzed using the Poisson regression with the age group as a categorical main effect and the period as a continuous one. The final analysis does not include an interaction between the age group and the period since it was not found to be significant. The analysis was done for the total group of germ cell tumors as well as for the two subcategories i.e. dysgerminoma and other germ cell tumors, separately. The epithelial tumors Poisson regression analysis was done only for the borderline subgroup because the invasive neoplasms comprised only eight cases. The significance of the effects and their approximate 95% confidence intervals (CI) in subgroups analyses were evaluated using Bonefferoni s correction for multiple comparisons. Differences were considered significant when p was In the 0 4 year age group a single two year old patient was diagnosed. Since ovarian tumors are extremely rare in this age group, IRs were calculated for ages 0 19 as well as for ages This case was subsequently excluded from further analysis. During the entire 25 years study period, only nine non Jewish (Arab and Druse) patients with ovarian malignancies were diagnosed. Because of the small number and different epidemiological pattern in the non Jewish population, they were not included in this report. Results During the study period, 82 Jewish patients Æ19 years old with ovarian malignancies were recorded in the Israel Cancer Registry. These comprised 1.3% of the total number of ovarian malignancies diagnosed during that period. The IR for the total group of ovarian malignancies in the 0 19 years age group was 0.66 and for ages 5 19 it was 0.71 per 100,000. The distribution of the patients according to the histologic type and subtype is presented in Table I. The most frequent tumors were of germ cell origin (72.0%) and about one third of these (19 of 59) were dysgerminomas. Among the 15 patients with mixed germ cell tumors, five also contained dysgerminomatous elements. Epithelial tumors were di-

3 Childhood and adolescent ovarian malignancies 815 agnosed in 25.6% of the patients and most of these (13 of %) were borderline malignancies. The median age of the patients with germ cell tumors was 14 years. The youngest was 2 years old and had an immature teratoma. The median age of patients with epithelial tumors was 17 years and the youngest was 9 years old and had invasive serous cystadenocarcinoma. In addition, only two cases had sex cord tumors, both were in the year age group and were diagnosed in the period. Age specific IRs by time period for germ cell tumors are shown in Table II. The total IR of germ cell tumors for the entire study period is 0.47 for ages 0 19 and 0.5 for ages 5 19 per 100,000. These IRs show a marked decrease over time from 0.69 to 0.32 (from to ). The decrease seems to have occurred since This decrease is prominent in dysgerminomas, while the IRs of the other germ cell tumors seem to remain stable over time. Among the germ cell tumors the relative frequency of dysgerminoma decreased from 7/13 (53.8%) during the first five year period to only 1/ 9 (11.1%) during the last five year period. However, this difference did not reach statistical significance (pω0.074). In the youngest age groups, nondysgerminomatous neoplasms predominated. The age specific IRs of epithelial tumors are shown in Table III. The IR for the total group of epithelial tumors was 0.18 and for invasive tumors only No trend was observed in the IRs of the total epithelial group over time. However a steep rise is noticed in the last five year period, reaching to 0.36 per 100,000, that probably reflects the IR increase of borderline tumors. The lowest age specific IR was observed in the youngest age group (0.27 and 0.02 for germ cell tumors and epithelial tumors respectively). Table IV shows that after adjustment for age, there is a significant (p 0.05) linear trend of decrease in the IRs of germ cell tumors over time, with a rate ratio of This trend stems especially from the dysgerminomas where the rate ratio is 0.62, i.e. every five years the IRs decrease by an estimated 38% and are significantly different from 1 even after correction for multiple comparisons (p 0.025). This period effect was not found in the other germ cell group, where the IRs seem to be stable over the periods after adjustment for agegroup. Table IV also shows a significant trend of increase in the age specific IRs of germ cell tumors with age. The age specific IRs in the age group are 2.7 times higher than in the 5 9 age group. This trend of age effect is seen in both germ cell tumor subtypes but it reaches significance only in the dysgerminomas (rate ratioω6.68; 95% CIΩ ). The Poisson regression analysis of the borderline subtype was conducted only for the age Table II. Age specific incidence rates of total germ cell tumors and main subtypes per 100,000 in the female Jewish population in Israel (aged 5 19 years) Period Total No. IR No. IR No. IR No. IR No. IR No. IR *Total germ-cell Tumors Total Dysgerminoma Total *Other germ Cell Tumors Total * One two year old girl diagnosed in the period , is excluded from the Table.

4 816 J. Menczer et al. Table III. Age specific incidence rates of total epithelial tumors and main subtypes per 100,000 in the female Jewish population in Israel (aged 5 19 years) Period Total No. IR No. IR No. IR No. IR No. IR No. IR Total epithelial Total Borderline Total Invasive Total group since all the cases belonged to this group. This analysis shows an increase over time with an estimated rate ratio of 1.76 (95% CIΩ[ ]) for the period effect. Discussion As in other countries (5 7) the majority of ovarian malignancies in childhood and adolescence in Israel, in a previous (8) and the present report, were of germ cell origin. The total IRs of ovarian malignancies in general as well as of germ cell tumors in this age group were very low (0.71 and 0.5 per 100,000 respectively). Our data seem to indicate an age specific IR change over time in the germ cell tumors, that resulted from the significant decrease in the IR of dysgerminomas. The etiology of dysgerminoma is unknown and, therefore, the reason for the significant incidence decline of this tumor is obscure. In previous studies the estimated overall notifi- Table IV. Estimates of rate ratio and 95% CI of germ cell incidence rates by age group and period (Poisson regression) All germ cell Dysgerminoma Other germ cell Variable RR (95% CI) RR (95% CI) RR (95% CI) Age ( )* 2.71 ( ) 1.92 ( ) ( )* 6.68 ( )** 1.77 ( ) Period 0.83 ( )* 0.62 ( )** 0.95 ( ) *p **p cation failure to the Israel Cancer Registry was found to be only about 5% in all age groups (9, 10). It is unreasonable to assume that the age specific IR decline of dysgerminoma is due to less accurate notification of the Registry with time, of this tumor alone. A possible explanation may be a change in the population such as the mass immigration from the former Soviet Union during the last 5 year study period. The young new immigrants may have a lower incidence of such tumors. Obviously, a true age specific incidence decline cannot be ruled out. Malignant epithelial ovarian tumors account only for a minority of ovarian tumors in the young. In a compilation of reports published from 1965 to 1991, Deprest et al. (11) found only 97 patients under the age of 20 with epithelial malignancies and the youngest reported cases were 4 years old (12, 13). Our data are in line with these findings. In the compilation by Deprest et al. (11), only 30% were of borderline malignancy, while in the present study most epithelial tumors (61.9%) were of borderline malignancy. This discrepancy may be due to differences between populations or because of variability in histological interpretation. It is noteworthy that the proportion of borderline epithelial ovarian tumors in adults is only about 10% (14). Our data show a significant trend of age specific IRs increase with time of borderline tumors. These results may be attributed to greater awareness of pathologists to this histological entity. However, due to the small number of cases and the steep

5 Childhood and adolescent ovarian malignancies 817 increase that occurred in the latest period, these results should be regarded with caution. Finally, even though in our study only eight invasive epithelial ovarian malignancies (four serous and two each mucinous and small cell) were observed during the entire 25 year study period, one should bear in mind this rare possibility during the management of ovarian cysts even in children and adolescents. The etiology of most ovarian epithelial neoplasms is attributed to incessant ovulation and environmental factors. However, it is doubtful that these factors also apply in the very young. Recently mutations in the BRCA1/2 genes have been implicated in the etiology of young onset ovarian cancer, especially in women with a history of familial ovarian cancer (15). Regretfully the family history and the gene status of our very young patients with epithelial ovarian tumors are unknown. References 1. Barchana M, Andreev H, Alon R. Israel Cancer Registry. Cancer in Israel, Jerusalem, Mor-Yosef S, Abraham R, Schenker JG. Ovarian cancer in Israel Harefuah 1997; 132: Serov SF, Scully RE, Sobin LJ. Histologic typing of ovarian tumors. In: World Health Organization. International histological classification of tumors. Geneva: The World Health Organization, Gershenson DM. Update on malignant ovarian germ cell tumors. Cancer 1993; 71: Norris HJ, Jensen RD. Relative frequency of ovarian neoplasms in children and adolescents. Cancer 1972; 30: La Vecchia C, Morris HB, Draper GJ. Malignant ovarian tumors in childhood in Britain Br J Cancer 1983; 48: Vani R, Kuntal R, Rao PL. Ovarian tumors in the second decade of life. Asia Oceania J Obstet Gynecol 1991; 17: Anteby SO, Mor-Yosef S, Schenker JG. Ovarian cancer in the young. Eur J Gynaecol Oncol 1985; 6: Tulchinsky D, Modan B. Epidemiological aspects of cancer of the stomach in Israel. Cancer 1967; 20: Menczer J, Modan B, Oelsner G, Sharon Z, Sampson S. Adenocarcinoma of the uterine cervix. A distinct epidemiologic entity. Cancer 1978; 41: Deprest J, Moerman P, Corneillie P, Ide P. Ovarian borderline mucinous tumor in a premenarchal girl: A review on ovarian epithelial cancer in young girls. Gynecol Oncol 1992; 45: Hong SJ, Lurain JR, Tsukada Y, Piver MS, Humbert JR, Freeman AI. Cystadenocarcinoma of the ovary in a 4-year old: Benign transformation during therapy. Cancer 1980; 45: Blom GP, Torkildsen EM. Ovarian cystadenocarcinoma in a 4-year-old girl: Report of a case and review of the literature. Gynecol Oncol 1982; 13: Younessi M, Crickard K, Celik C, Yoonessi S. Borderline epithelial tumors of the ovary: Ovarian intraepithelial neoplasia. Obstet Gynecol Surv 1988; 43: Boyd J, Rubin SC. Hereditary ovarian cancer: Molecular genetics and clinical applications. Gynecol Oncol 1997; 64: Address for correspondence: Prof. Joseph Menczer, M.D. Director Gynecologic Oncology Unit Department of Obstetrics and Gynecology Edith Wolfson Medical Center Holon 58100, Israel

Pediatric ovarian neoplastic tumors: incidence, age at presentation, tumor markers and outcome

Pediatric ovarian neoplastic tumors: incidence, age at presentation, tumor markers and outcome A C TA Obstetricia et Gynecologica AOGS MAIN RESEARCH ARTICLE Pediatric ovarian neoplastic tumors: incidence, age at presentation, tumor markers and outcome SEPPO TASKINEN 1, RIITTA FAGERHOLM 1, JOUKO

More information

Institute of Pathology First Faculty of Medicine Charles University. Ovary

Institute of Pathology First Faculty of Medicine Charles University. Ovary Ovary Barrett esophagus ph in vagina between 3.8 and 4.5 ph of stomach varies from 1-2 (hydrochloric acid) up to 4-5 BE probably results from upward migration of columnar cells from gastroesophageal junction

More information

3 cell types in the normal ovary

3 cell types in the normal ovary Ovarian tumors 3 cell types in the normal ovary Surface (coelomic epithelium) the origin of the great majority of ovarian tumors 90% of malignant ovarian tumors Totipotent germ cells Sex cord-stromal cells

More information

3 cell types in the normal ovary

3 cell types in the normal ovary Ovarian tumors 3 cell types in the normal ovary Surface (coelomic epithelium) the origin of the great majority of ovarian tumors (neoplasms) 90% of malignant ovarian tumors Totipotent germ cells Sex cord-stromal

More information

Histopathological Study of Ovarian Lesions

Histopathological Study of Ovarian Lesions Histopathological Study of Ovarian Lesions Nirali N. Thakkar 1, Shaila N. Shah 2 1 Resident doctor, Pathology department, Government Medical College, Bhavnagar-364001, India 2 Head of the department, Pathology

More information

OVARIES. MLS Basic histological diagnosis MLS HIST 422 Semester 8- batch 7 L13 Dr: Ali Eltayb.

OVARIES. MLS Basic histological diagnosis MLS HIST 422 Semester 8- batch 7 L13 Dr: Ali Eltayb. OVARIES MLS Basic histological diagnosis MLS HIST 422 Semester 8- batch 7 L13 Dr: Ali Eltayb. OBJECTIVES Recognize different disease of ovaries Classify ovarian cyst Describe the pathogenesis, morphology

More information

Histological pattern of ovarian tumors and their age distribution

Histological pattern of ovarian tumors and their age distribution Original Article Nepal Med Coll J 2008; 10(2): 81-85 Histological pattern of ovarian s and their age distribution R Jha and S Karki Department of Pathology, TUTH, Maharajgunj, Kathmandu, Nepal Corresponding

More information

Clinicopathological and Histological Features of Ovarian Tumour- A Study

Clinicopathological and Histological Features of Ovarian Tumour- A Study IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 9 Ver. IX (September. 2017), PP 56-60 www.iosrjournals.org Clinicopathological and Histological

More information

Inherited Ovarian Cancer Diagnosis and Prevention

Inherited Ovarian Cancer Diagnosis and Prevention Inherited Ovarian Cancer Diagnosis and Prevention Dr. Jacob Korach - Deputy director Gynecologic Oncology (past chair - Israeli Society of Gynecologic Oncology) Prof. Eitan Friedman - Head, Oncogenetics

More information

See the latest estimates for new cases of ovarian cancer and deaths in the US and what research is currently being done.

See the latest estimates for new cases of ovarian cancer and deaths in the US and what research is currently being done. About Ovarian Cancer Overview and Types If you have been diagnosed with ovarian cancer or are worried about it, you likely have a lot of questions. Learning some basics is a good place to start. What Is

More information

Survival of ovarian cancer patients in Denmark: Excess mortality risk analysis of five-year relative survival in the period

Survival of ovarian cancer patients in Denmark: Excess mortality risk analysis of five-year relative survival in the period Acta Obstetricia et Gynecologica. 2008; 87: 13531360 ORIGINAL ARTICLE Survival of ovarian cancer patients in Denmark: Excess mortality risk analysis of five-year relative survival in the period 1978 2002

More information

JMSCR Vol 04 Issue 06 Page June 2016

JMSCR Vol 04 Issue 06 Page June 2016 www.jmscr.igmpublication.org Impact Factor 5.244 Index Copernicus Value: 5.88 ISSN (e)-2347-76x ISSN (p) 2455-0450 DOI: http://dx.doi.org/0.8535/jmscr/v4i6.33 Clinico Pathological Study of Ovarian Tumors-

More information

Springer Healthcare. Understanding and Diagnosing Ovarian Cancer. Concise Reference: Krishnansu S Tewari, Bradley J Monk

Springer Healthcare. Understanding and Diagnosing Ovarian Cancer. Concise Reference: Krishnansu S Tewari, Bradley J Monk Concise Reference: Understanding and Diagnosing Ovarian Cancer Krishnansu S Tewari, Bradley J Monk Extracted from: The 21 st Century Handbook of Clinical Ovarian Cancer Published by Springer Healthcare

More information

Pathology of Ovarian Tumours. Dr. Jyothi Ranganathan MD ( Path) AFMC Pune PDCC (Cytopathology) PGI Chandigarh

Pathology of Ovarian Tumours. Dr. Jyothi Ranganathan MD ( Path) AFMC Pune PDCC (Cytopathology) PGI Chandigarh Pathology of Ovarian Tumours Dr. Jyothi Ranganathan MD ( Path) AFMC Pune PDCC (Cytopathology) PGI Chandigarh Outline Incidence Risk factors Classification Pathology of tumours Tumour markers Prevention

More information

Ovarian masses in children and adolescents in China: analysis of 203 cases

Ovarian masses in children and adolescents in China: analysis of 203 cases Liu et al. Journal of Ovarian Research 2013, 6:47 RESEARCH Open Access Ovarian masses in children and adolescents in China: analysis of 203 cases Hongqian Liu 1,2,3,4, Xiangao Wang 5, Donghao Lu 1,6, Zhihong

More information

Gynecologic Cancer Surveillance and Survivorship: Informing Practice and Policy

Gynecologic Cancer Surveillance and Survivorship: Informing Practice and Policy Gynecologic Cancer Surveillance and Survivorship: Informing Practice and Policy Stephanie Yap, M.D. University Gynecologic Oncology Northside Cancer Institute Our Learning Objectives Review survival rates,

More information

Rare ovarian tumours Page 1 of 6 Ovacome

Rare ovarian tumours Page 1 of 6 Ovacome Fact sheet 12 Rare ovarian tumours Ovacome is a national charity providing advice and support to women with ovarian cancer. We give information about symptoms, diagnosis, treatment, research and screening.

More information

Gynaecological Malignancies

Gynaecological Malignancies Gynaecological Malignancies Dr Rodney Itaki Lecturer Anatomical Pathology Discipline University of Papua New Guinea Division of Pathology School of Medicine & Health Sciences Overview Genital tract tumors

More information

Bleeding symptoms and subsequent risk of gynecological and other cancers

Bleeding symptoms and subsequent risk of gynecological and other cancers Acta Obstet Gynecol Scand 1998; 77: 564 569 Copyright C Acta Obstet Gynecol Scand 1998 Printed in Denmark all rights reserved Acta Obstetricia et Gynecologica Scandinavica ISSN 0001-6349 ORIGINAL ARTICLE

More information

Ovarian Tumors: A Study of 2146 Cases at AFIP, Rawalpindi, Pakistan.

Ovarian Tumors: A Study of 2146 Cases at AFIP, Rawalpindi, Pakistan. Ovarian Tumors: A Study of 2146 Cases at AFIP, Rawalpindi, Pakistan. 1 Muhammad Zubair, 2 Shoaib Naiyar Hashmi, 3 Saeed Afzal, 4 Iqbal Muhammad, 5 Hafeez Ud Din, 6 Syed Naeem Raza Hamdani, 7 Rabia Ahmad.

More information

Tetsuro Yahata, Chiaki Banzai, Kenichi Tanaka and Niigata Gynecological Cancer Registry

Tetsuro Yahata, Chiaki Banzai, Kenichi Tanaka and Niigata Gynecological Cancer Registry 645..650 doi:10.1111/j.1447-0756.2011.01755.x J. Obstet. Gynaecol. Res. Vol. 38, No. 4: 645 650, April 2012 Histology-specific long-term trends in the incidence of ovarian cancer and borderline tumor in

More information

RESEARCH COMMUNICATION

RESEARCH COMMUNICATION RESEARCH COMMUNICATION Clinicopathologic Analysis of Women with Synchronous Primary Carcinomas of the Endometrium and Ovary: 10- Year Experience from Chiang Mai University Hospital Jiraprapa Natee 1 *,

More information

Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology

Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology bs_bs_banner doi:10.1111/jog.12596 J. Obstet. Gynaecol. Res. Vol. 41, No. 2: 167 177, February 2015 Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology

More information

Histopathological analysis of neoplastic and non neoplastic lesions of ovary: A study of one hundred cases

Histopathological analysis of neoplastic and non neoplastic lesions of ovary: A study of one hundred cases Orginal Article Histopathological analysis of neoplastic and non neoplastic lesions of ovary: A study of one hundred cases 2 G Prathima, Srikanth Shastry 2 Consultant Pathologist, Image Diagnostics, Kadapa,

More information

Clinical outcome of cystectomy compared with unilateral salpingo-oophorectomy as fertility-sparing treatment of borderline ovarian tumors

Clinical outcome of cystectomy compared with unilateral salpingo-oophorectomy as fertility-sparing treatment of borderline ovarian tumors REPRODUCTIVE SURGERY Clinical outcome of cystectomy compared with unilateral salpingo-oophorectomy as fertility-sparing treatment of borderline ovarian tumors Yoav Yinon, M.D., Mario E. Beiner, M.D., Walter

More information

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

PDF hosted at the Radboud Repository of the Radboud University Nijmegen PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/24096

More information

How to Recognize Gynecologic Cancer Cells from Pelvic Washing and Ascetic Specimens

How to Recognize Gynecologic Cancer Cells from Pelvic Washing and Ascetic Specimens How to Recognize Gynecologic Cancer Cells from Pelvic Washing and Ascetic Specimens Wenxin Zheng, M.D. Professor of Pathology and Gynecology University of Arizona zhengw@email.arizona.edu http://www.zheng.gynpath.medicine.arizona.edu/index.html

More information

GYNECOLOGIC MALIGNANCIES: Ovarian Cancer

GYNECOLOGIC MALIGNANCIES: Ovarian Cancer GYNECOLOGIC MALIGNANCIES: Ovarian Cancer KRISTEN STARBUCK, MD ROSWELL PARK CANCER INSTITUTE DEPARTMENT OF SURGERY DIVISION OF GYNECOLOGIC ONCOLOGY APRIL 19 TH, 2018 Objectives Basic Cancer Statistics Discuss

More information

Gynecology-endocrinology

Gynecology-endocrinology Gynecology-endocrinology FERTILITY AND STERILITY Copyright 1996 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Human menopausal gonadotropin and the risk of epithelial

More information

JMSCR Vol 3 Issue 9 Page September 2015

JMSCR Vol 3 Issue 9 Page September 2015 www.jmscr.igmpublication.org Impact Factor 3.79 ISSN (e)-2347-176x DOI: http://dx.doi.org/10.18535/jmscr/v3i9.09 A Study of Histopathological Pattern of Ovarian Neoplasms and their Age Distribution in

More information

Incidence, Histological Types and Age at Presentation of Borderline and Malignant Ovarian Tumors at a Tertiary Institute in Nepal

Incidence, Histological Types and Age at Presentation of Borderline and Malignant Ovarian Tumors at a Tertiary Institute in Nepal NJOG 01 Jul-Dec; 18 ():11-16 Original Article Incidence, Histological Types and Age at Presentation of Borderline and Malignant Ovarian Tumors at a Tertiary Institute in Nepal Deptartment of Obstetrics

More information

Original Article Histological patterns of Ovarian neoplasms A five year experience in North-East India Saha M 1, Banerjee A 2, Datta A 3

Original Article Histological patterns of Ovarian neoplasms A five year experience in North-East India Saha M 1, Banerjee A 2, Datta A 3 Original Article Histological patterns of Ovarian neoplasms A five year experience in North-East India Saha M 1, Banerjee A 2, Datta A 3 1 Dr Manasi Saha (Ray) Associate Professor saharaydrmanasi@gmail.com

More information

Annual report of Gynecologic Oncology Committee, Japan Society of Obstetrics and Gynecology, 2013

Annual report of Gynecologic Oncology Committee, Japan Society of Obstetrics and Gynecology, 2013 bs_bs_banner doi:10.1111/jog.12360 J. Obstet. Gynaecol. Res. Vol. 40, No. 2: 338 348, February 2014 Annual report of Gynecologic Oncology Committee, Japan Society of Obstetrics and Gynecology, 2013 Daisuke

More information

Female Reproduc.ve System. Kris.ne Kra7s, M.D.

Female Reproduc.ve System. Kris.ne Kra7s, M.D. Female Reproduc.ve System Kris.ne Kra7s, M.D. Female Reproduc.ve System Outline Cervix Uterus Ovaries Breast Female Reproduc.ve System Outline Cervix Cervical carcinoma Cervical Carcinoma Once the most

More information

Female Reproduc.ve System. Kris.ne Kra7s, M.D.

Female Reproduc.ve System. Kris.ne Kra7s, M.D. Female Reproduc.ve System Kris.ne Kra7s, M.D. Female Reproduc.ve System Outline Cervix Uterus Ovaries Breast Cervical Carcinoma Once the most common cancer in women now not even in top 10. Decrease due

More information

Icd 10 ovarian stroma

Icd 10 ovarian stroma Icd 10 ovarian stroma Struma ovarii; Micrograph of a struma ovarii. Characteristic thyroid follicles are seen on the right, and ovarian stroma on the left. H&E stain. Classification and. Free, official

More information

Background. Background. Background. Background 2/2/2015. Endometriosis-Associated Ovarian Cancer: Malignant Transformation of Endometriosis

Background. Background. Background. Background 2/2/2015. Endometriosis-Associated Ovarian Cancer: Malignant Transformation of Endometriosis Endometriosis-Associated Ovarian Cancer: Malignant Transformation of Endometriosis I have no disclosures. Marcela G. del Carmen, MD, MPH Associate Professor Division of Gynecologic Oncology EOC is gynecologic

More information

Christian Marth, MD, PhD Department of Obstetrics and Gynecology Innsbruck Medical University Innsbruck, Austria

Christian Marth, MD, PhD Department of Obstetrics and Gynecology Innsbruck Medical University Innsbruck, Austria Christian Marth, MD, PhD Department of Obstetrics and Gynecology Innsbruck Medical University Innsbruck, Austria Classification of Ovarian Neoplasms Origin Surface Epithelial Cells Germ Cells Sex Cord

More information

Histological Pattern of Ovarian Neoplasma

Histological Pattern of Ovarian Neoplasma Histological Pattern of Ovarian Neoplasma Zubair Ahmad,Naila Kayani,Sheema H. Hasan,Suhail Muzaffar ( Department of Pathology, The Aga Khan University Hospital, Karachi. ) Muhammad Shafiq Gill ( Department

More information

International Society of Gynecological Pathologists Symposium 2007

International Society of Gynecological Pathologists Symposium 2007 International Society of Gynecological Pathologists Symposium 2007 Anais Malpica, M.D. Department of Pathology The University of Texas M.D. Anderson Cancer Center Grading of Ovarian Cancer Histologic grade

More information

A Survay on Appendiceal Involvement in Ovarian Mucinous Tumors

A Survay on Appendiceal Involvement in Ovarian Mucinous Tumors http://www.ijwhr.net Open Access doi 10.15296/ijwhr.2018.33 Original Article International Journal of Women s Health and Reproduction Sciences Vol. 6, No. 2, April 2018, 199 203 ISSN 2330-4456 A Survay

More information

Malignant transformation in benign cystic teratomas, dermoids of the ovary

Malignant transformation in benign cystic teratomas, dermoids of the ovary European JournalofObstetrics& Gynecology andreproductivebiology, 29 (1988) 197-206 197 Elsevier EJO 00716 Malignant transformation in benign cystic teratomas, dermoids of the ovary S. Chadha 1 and A. Schaberg

More information

Histopathological Study of Spectrum of Lesions Seen in Surgically Resected Specimens of Fallopian Tube

Histopathological Study of Spectrum of Lesions Seen in Surgically Resected Specimens of Fallopian Tube Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijss/2016/613 Histopathological Study of Spectrum of Lesions Seen in Surgically Resected Specimens of Fallopian Tube Pratima

More information

Cytology and Surgical Pathology of Gynecologic Neoplasms

Cytology and Surgical Pathology of Gynecologic Neoplasms Cytology and Surgical Pathology of Gynecologic Neoplasms Current Clinical Pathology ANTONIO GIORDANO, MD, PHD SERIES EDITOR For further titles published in this series, go to http://www.springer.com/springer/series/7632

More information

Mucinous cystadenocarcinoma of ovary with metastasis in 14-year-old girl

Mucinous cystadenocarcinoma of ovary with metastasis in 14-year-old girl Case Report Obstet Gynecol Sci 2017;60(2):227-231 https://doi.org/10.5468/ogs.2017.60.2.227 pissn 2287-8572 eissn 2287-8580 Mucinous cystadenocarcinoma of ovary with metastasis in 14-year-old girl Barkha

More information

L/O/G/O. Ovarian Tumor. Xiaoyu Niu Obstetrics and Gynecology Department Sichuan University West China Second Hospital

L/O/G/O. Ovarian Tumor. Xiaoyu Niu Obstetrics and Gynecology Department Sichuan University West China Second Hospital L/O/G/O Ovarian Tumor Xiaoyu Niu Obstetrics and Gynecology Department Sichuan University West China Second Hospital Essentials classification of ovarian tumor clinical manifestation of ovarian tumor metastatic

More information

Note: The cause of testicular neoplasms remains unknown

Note: The cause of testicular neoplasms remains unknown - In the 15- to 34-year-old age group, they are the most common tumors of men. - Tumors of the testis are a heterogeneous group of neoplasms that include: I. Germ cell tumors : 95%; all are malignant.

More information

Leukaemia 35% Lymphoma 14%

Leukaemia 35% Lymphoma 14% Distribution ib ti of Cancers in Children under 15 years Leukaemia 35% Lymphoma 14% Neuroblastoma 9% Other 5% Liver 1% Retinoblastoma 3% Bone and STS 15% CNS 20% Wilms' 8% 30-40% Mortality Germ Cell Tumours

More information

7 Mousa. Obada Zalat. Mohammad Badi

7 Mousa. Obada Zalat. Mohammad Badi 7 Mousa Obada Zalat Mohammad Badi Tumors of the ovaries Last lecture we talked about surface epithelial tumors of the ovaries (the most common type). But there are many other types of tumors of germ cell

More information

Cancer arising from Endometriosis and Its Clinical implications

Cancer arising from Endometriosis and Its Clinical implications Cancer arising from Endometriosis and Its Clinical implications 1) Nezhat F, Cohen C, Rahaman J, Gretz H, Cole P, Kalir T. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign

More information

Intratumoral Blood Flow Analysis in Ovarian Cancer:

Intratumoral Blood Flow Analysis in Ovarian Cancer: Intratumoral Blood Flow Analysis in Ovarian Cancer: What Does It Mean? Kohkichi Hata, MD, PhD, Toshiyuki Hata, MD, PhD The objective of this study is to evaluate the significance of intratumoral blood

More information

Stage IIIC transitional cell carcinoma and serous carcinoma of the ovary have similar outcomes when treated with platinum-based chemotherapy

Stage IIIC transitional cell carcinoma and serous carcinoma of the ovary have similar outcomes when treated with platinum-based chemotherapy Original Investigation 33 Stage IIIC transitional cell carcinoma and serous carcinoma of the ovary have similar outcomes when treated with platinum-based chemotherapy Gökhan Boyraz, Derman Başaran, Mehmet

More information

Current Concept in Ovarian Carcinoma: Pathology Perspectives

Current Concept in Ovarian Carcinoma: Pathology Perspectives Current Concept in Ovarian Carcinoma: Pathology Perspectives Rouba Ali-Fehmi, MD Professor of Pathology The Karmanos Cancer Institute, Wayne State University School of Medicine Current Concept in Ovarian

More information

EDUCATIONAL COMMENTARY CA 125. Learning Outcomes

EDUCATIONAL COMMENTARY CA 125. Learning Outcomes EDUCATIONAL COMMENTARY CA 125 Learning Outcomes Upon completion of this exercise, participants will be able to: discuss the use of CA 125 levels in monitoring patients undergoing treatment for ovarian

More information

JMSCR Vol 04 Issue 12 Page December 2016

JMSCR Vol 04 Issue 12 Page December 2016 www.jmscr.igmpublication.org Impact Factor 5.244 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v4i12.120 A Study of Clinicomorphological Profile

More information

Mucinous Adenocarcinoma Involving the Ovary: Comparative Evaluation of the Classification Algorithms using Tumor Size and Laterality

Mucinous Adenocarcinoma Involving the Ovary: Comparative Evaluation of the Classification Algorithms using Tumor Size and Laterality J Korean Med Sci 2010; 25: 220-5 ISSN 1011-8934 DOI: 10.3346/jkms.2010.25.2.220 Mucinous Adenocarcinoma Involving the Ovary: Comparative Evaluation of the Classification Algorithms using Tumor Size and

More information

Gynecologic Oncologist. Surgery Chemotherapy Radiation Therapy Hormonal Therapy Immunotherapy. Cervical cancer

Gynecologic Oncologist. Surgery Chemotherapy Radiation Therapy Hormonal Therapy Immunotherapy. Cervical cancer Gynecologic Oncology Pre invasive vulvar, vaginal, & cervical disease Vulvar Cervical Endometrial Uterine Sarcoma Fallopian Tube Ovarian GTD Gynecologic Oncologist Surgery Chemotherapy Radiation Therapy

More information

Ovarian Clear Cell Carcinoma

Ovarian Clear Cell Carcinoma Ovarian Clear Cell Carcinoma Rouba Ali-Fehmi, MD Professor of Pathology The Karmanos Cancer Institute, Wayne State University School of Medicine 50 year old woman with chief complaint of shortness of breath

More information

Serous borderline tumor icd 10

Serous borderline tumor icd 10 Note. May be used as an additional code to identify functional activity associated with a carcinoid tumor. Free, official information about 2012 (and also 2013-2015) ICD -9-CM diagnosis code 220, including

More information

Ovarian Germ Cell Tumor Histopathological and statistical analysis

Ovarian Germ Cell Tumor Histopathological and statistical analysis Nepal Medical Association Building Exhibition Road, Kathmandu Journal of Pathology of Nepal (23) Vol. 3, 44 446 Association of Clinical Pathologist of Nepal2 Journal of PATHOLOGY of Nepal www.acpnepal.com

More information

RESEARCH ARTICLE. Usanee Chatchotikawong 1, Irene Ruengkhachorn 1 *, Chairat Leelaphatanadit 1, Nisarat Phithakwatchara 2. Abstract.

RESEARCH ARTICLE. Usanee Chatchotikawong 1, Irene Ruengkhachorn 1 *, Chairat Leelaphatanadit 1, Nisarat Phithakwatchara 2. Abstract. RESEARCH ARTICLE 8-year Analysis of the Prevalence of Lymph Nodes Metastasis, Oncologic and Pregnancy Outcomes in Apparent Early-Stage Malignant Ovarian Germ Cell Tumors Usanee Chatchotikawong 1, Irene

More information

Role of peritoneal washing cytology in ovarian malignancies: correlation with histopathological parameters

Role of peritoneal washing cytology in ovarian malignancies: correlation with histopathological parameters Naz et al. World Journal of Surgical Oncology (2015) 13:315 DOI 10.1186/s12957-015-0732-1 WORLD JOURNAL OF SURGICAL ONCOLOGY RESEARCH Open Access Role of peritoneal washing in ovarian malignancies: correlation

More information

The diagnostic value of determination of serum GOLPH3 associated with CA125, CA19.9 in patients with ovarian cancer

The diagnostic value of determination of serum GOLPH3 associated with CA125, CA19.9 in patients with ovarian cancer European Review for Medical and Pharmacological Sciences 2017; 21: 4039-4044 The diagnostic value of determination of serum GOLPH3 associated with CA125, CA19.9 in patients with ovarian cancer H.-Y. FAN

More information

Low-grade serous neoplasia. Robert A. Soslow, MD

Low-grade serous neoplasia. Robert A. Soslow, MD Low-grade serous neoplasia Robert A. Soslow, MD soslowr@mskcc.org Outline Orientation Ovarian tumor overview Non serous borderline tumors Serous borderline tumors Clinical summary Morphologic description

More information

Ovarian cancer: 2012 Update Srini Prasad MD Univ Texas MD Anderson Cancer Center

Ovarian cancer: 2012 Update Srini Prasad MD Univ Texas MD Anderson Cancer Center Ovarian cancer: 2012 Update Srini Prasad MD Univ Texas MD Anderson Cancer Center Ovarian cancer is not a single disease Ovarian Epithelial Tumors: Histological Spectrum* Type Frequency Histology High-Grade

More information

TEENAGE GYNECOLGICAL PROBLEMS. PROF. MAHMOUD YOUSSEF ABDALLA FACLTY OF MEDECINE,AIN SHAMS UNIVERSITY.

TEENAGE GYNECOLGICAL PROBLEMS. PROF. MAHMOUD YOUSSEF ABDALLA FACLTY OF MEDECINE,AIN SHAMS UNIVERSITY. TEENAGE GYNECOLGICAL PROBLEMS PROF. MAHMOUD YOUSSEF ABDALLA FACLTY OF MEDECINE,AIN SHAMS UNIVERSITY. www.mahobsgyn.com TEENAGE GYNECOLOGICAL PROBLEMS امراض الجهاز التناسلى للفتيات Teenage gynecological

More information

Fast Facts: Ovarian Cancer

Fast Facts: Ovarian Cancer Fast Facts Fast Facts: Ovarian Cancer Christina Fotopoulou MD PhD Consultant Gynaecological Oncologist Queen Charlotte s and Chelsea Hospital London, UK Thomas J Herzog MD Professor of Obstetrics and Gynecology

More information

Partners: Introductions: Dr. Carolyn Johnston Deanna Cosens & Ann Garvin. Ovarian Cancer and Primary Care July 16, :00 9:00am EST 7/16/2014

Partners: Introductions: Dr. Carolyn Johnston Deanna Cosens & Ann Garvin. Ovarian Cancer and Primary Care July 16, :00 9:00am EST 7/16/2014 Welcome To The Webinar Technical Support Ovarian Cancer and Primary Care July 16, 2014 8:00 9:00am EST In order to hear the presentation please call 1 (626) 544-0058, access code 167-314-644, followed

More information

Invited Re vie W. Molecular genetics of ovarian carcinomas. Histology and Histo pathology

Invited Re vie W. Molecular genetics of ovarian carcinomas. Histology and Histo pathology Histol Histopathol (1 999) 14: 269-277 http://www.ehu.es/histol-histopathol Histology and Histo pathology Invited Re vie W Molecular genetics of ovarian carcinomas J. Diebold Pathological Institute, Ludwig-Maximilians-University

More information

Overview of 2010 Hong Kong Cancer Statistics

Overview of 2010 Hong Kong Cancer Statistics Overview of 2010 Hong Kong Cancer Statistics Cancer Registration in Hong Kong The Hong Kong Cancer Registry has since the 1960s been providing population-based cancer data for epidemiological research

More information

Primary peritoneal and ovarian cancers: an epidemiological comparative analysis

Primary peritoneal and ovarian cancers: an epidemiological comparative analysis Cancer Causes Control (2010) 21:991 998 DOI 10.1007/s10552-010-9525-6 ORIGINAL PAPER Primary peritoneal and ovarian cancers: an epidemiological comparative analysis Delores J. Grant Patricia G. Moorman

More information

Pathology of the female genital tract

Pathology of the female genital tract Pathology of the female genital tract Common illnesses of the female genital tract Before menarche Developmental anomalies Tumors (ovarial teratoma) Amenorrhea Fertile years PCOS, ovarian cysts Endometriosis

More information

Ovarian masses in infant-juvenile age

Ovarian masses in infant-juvenile age Original article Arch Argent Pediatr 2018;116(3):e359-e364 / e359 Ovarian masses in infant-juvenile age Kaan Sonmez, M.D. a, Zafer Turkyilmaz, M.D. a, Ramazan Karabulut, M.D. a and A.Can Basaklar, M.D.

More information

State of the Science: Current status of research relevant to GCT GCT Survivors Weekend April 16, 2011

State of the Science: Current status of research relevant to GCT GCT Survivors Weekend April 16, 2011 State of the Science: Current status of research relevant to GCT GCT Survivors Weekend April 16, 2011 Jubilee Brown, M.D. Associate Professor UT M.D. Anderson Cancer Center Ovarian Cancer 21,880 new cases

More information

RARE EPITHELIAL TUMOURS OF BREAST RARE EPITHELIAL TUMOURS OF CORPUS UTERI EPITHELIAL TUMOURS OF CERVIX UTERI

RARE EPITHELIAL TUMOURS OF BREAST RARE EPITHELIAL TUMOURS OF CORPUS UTERI EPITHELIAL TUMOURS OF CERVIX UTERI RARE TUMOURS OF THE FEMALE GENITAL SYSTEM 17% OF FEMALE GENITAL SYSTEM TUMOURS ARE RARE 3 093 553 RARE EPITHELIAL TUMOURS OF BREAST RARE EPITHELIAL TUMOURS OF CORPUS UTERI 6 7 % OF RARE TUMOURS OUT OF

More information

Journal of Rawalpindi Medical College (JRMC); 2016;20(4):

Journal of Rawalpindi Medical College (JRMC); 2016;20(4): Original Article Morphological Profile of Ovarian Tumours Bilquis Begum, Iram Nadeem Rana, Nadeem Ikram Department of Pathology, Rawalpindi Medical College, Rawalpindi Abstract Background: To study the

More information

Classification Of Tumours Who

Classification Of Tumours Who Classification Of Tumours Who 1 / 6 2 / 6 3 / 6 Classification Of Tumours Who The following is a simplified (deprecated) version of the last 2007 WHO classification of the tumours of the central nervous

More information

DRAFT. No. of cases/ deaths. categories. Number of X-ray exposures (for UK & Ireland only ever vs never)

DRAFT. No. of cases/ deaths. categories. Number of X-ray exposures (for UK & Ireland only ever vs never) Table 2.1. Cohort studies of X-ray and Andrieu et al. (2006) Europe & Canada Carr et al. (2002) US cohort X- rays for treatment of peptic ulcers 1601 female BRCA1 + BRCA2 carriers, aged 18+; disease ascertainment

More information

A pathological and clinical study of 706 primary tumours of the ovary in the largest tertiary hospital in Ghana

A pathological and clinical study of 706 primary tumours of the ovary in the largest tertiary hospital in Ghana Akakpo et al. BMC Women's Health (2017) 17:34 DOI 10.1186/s12905-017-0389-8 RESEARCH ARTICLE Open Access A pathological and clinical study of 706 primary tumours of the ovary in the largest tertiary hospital

More information

Article begins on next page

Article begins on next page Pseudopapillary Granulosa Cell Tumor: A Case of This Rare Subtype Rutgers University has made this article freely available. Please share how this access benefits you. Your story matters. [https://rucore.libraries.rutgers.edu/rutgers-lib/50622/story/]

More information

Adenocarcinoma of the Cervix

Adenocarcinoma of the Cervix Question 1. Each of the following statements about cervical adenocarcinoma is true except: Adenocarcinoma of the Cervix SAMS a) A majority of women with cervical adenocarcinoma have stage I tumors at diagnosis.

More information

Case 1. Pathology of gynecological cancer. What do we need to know (Case 1) Luca Mazzucchelli Istituto cantonale di patologia Locarno

Case 1. Pathology of gynecological cancer. What do we need to know (Case 1) Luca Mazzucchelli Istituto cantonale di patologia Locarno Case 1 Pathology of gynecological cancer. What do we need to know (Case 1) Luca Mazzucchelli Istituto cantonale di patologia Locarno SAMO Interdisciplinary Workshop on Gynecological Tumors Lucern, October

More information

ORIGINAL ARTICLE CA-125 AS A SURROGATE MARKER IN A CLINICAL AND HISTOPATHOLOGICAL STUDY OF PELVIC MASS AT A TERTIARY CARE HOSPITAL

ORIGINAL ARTICLE CA-125 AS A SURROGATE MARKER IN A CLINICAL AND HISTOPATHOLOGICAL STUDY OF PELVIC MASS AT A TERTIARY CARE HOSPITAL CA-125 AS A SURROGATE MARKER IN A CLINICAL AND HISTOPATHOLOGICAL STUDY OF PELVIC MASS AT A TERTIARY CARE HOSPITAL Madhuri Kulkarni 1, Ambarish Bhandiwad 2, Sunila R 3, Sumangala 4. 1. Professor, Department

More information

Prof. Dr. Aydın ÖZSARAN

Prof. Dr. Aydın ÖZSARAN Prof. Dr. Aydın ÖZSARAN Adenocarcinomas of the endometrium Most common gynecologic malignancy in developed countries Second most common in developing countries. Adenocarcinomas, grade 1 and 2 endometrioid

More information

Overview of 2013 Hong Kong Cancer Statistics

Overview of 2013 Hong Kong Cancer Statistics Overview of 2013 Hong Kong Cancer Statistics Cancer Registration in Hong Kong The Hong Kong Cancer Registry (HKCaR) is a population-based cancer registry, collecting the basic demographic data, information

More information

Borderline Ovarian Tumours. Andreas Obermair Brisbane

Borderline Ovarian Tumours. Andreas Obermair Brisbane Borderline Ovarian Tumours Andreas Obermair Brisbane Definition First described in 1929 Cellular features of malignancy Cellular atypia Mitotic activity No stromal invasion An entity per se??? (or precursor

More information

Endosalpingiosis. Case report

Endosalpingiosis. Case report Case report Endosalpingiosis Michael D. Holmes, M.D. Howard S. Levin M.D. Department of Pathology Lester A. Ballard, Jr., M.D. Department of Gynecology Endosalpingiosis, a term referring to tuballike epithelium

More information

JMSCR Vol 05 Issue 01 Pages January 2017

JMSCR Vol 05 Issue 01 Pages January 2017 JMSCR Vol 5 Issue 1 Pages 17214-17221 January 217 www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-45 DOI: https://dx.doi.org/1.18535/jmscr/v5i1.158

More information

Clinical statistics of gynecologic cancers in Japan

Clinical statistics of gynecologic cancers in Japan J Gynecol Oncol. 2017 Mar;28(2):e32 pissn 2005-0380 eissn 2005-0399 Review Article Clinical statistics of gynecologic cancers in Japan Wataru Yamagami, 1,7 Satoru Nagase, 2,7 Fumiaki Takahashi, 3 Kazuhiko

More information

Overview of Hong Kong Cancer Statistics of 2015

Overview of Hong Kong Cancer Statistics of 2015 Overview of Hong Kong Cancer Statistics of 2015 This report summarizes the key cancer statistics of Hong Kong for the year of 2015, which is now available on the website of Hong Kong Cancer Registry. Cancer

More information

Focus on... Ovarian cancer. HE4 & ROMA score

Focus on... Ovarian cancer. HE4 & ROMA score Focus on... Ovarian cancer HE4 & ROMA score Ovarian cancer in the world* Accounting for around 4% of all cancers diagnosed in women The estimated World age-standardised incidence rate for the more developed

More information

Sonographic Prediction of Ovarian Malignancy in Adnexal Mass

Sonographic Prediction of Ovarian Malignancy in Adnexal Mass Bangladesh J Obstet Gynaecol, 2012; Vol. 27(2) : 67-71 Sonographic Prediction of Ovarian Malignancy in Adnexal Mass SHAMSUN NAHAR 1, LATIFA SHAMSUDDIN 2, MARIAM FARUQUI 3, GULSHAN ARA 4 Abstract: Objective:

More information

The relative frequency and histopathological patterns of ovarian lesions: study of 116 cases

The relative frequency and histopathological patterns of ovarian lesions: study of 116 cases Original article: The relative frequency and histopathological patterns of ovarian lesions: study of 116 cases Dr Dimple Mehta*,Dr Alpesh Chavda**, Dr Hetal Patel*** *Assistant Professor, **Tutor, ***3

More information

Epidermoid Cyst of the Ovary

Epidermoid Cyst of the Ovary Epidermoid Cyst of the Ovary A eport of Three Cases with Comments on Histogenesis OBET H. YOUNG, M.B., JAIME PAT, M.D., AND OBET E. SCUY, M.D. Young, obert H., Prat, Jaime, and Scully, obert E.: Epidermoid

More information

H&E, IHC anti- Cytokeratin

H&E, IHC anti- Cytokeratin Cat No: OVC2281 - Ovary cancer tissue array Lot# Cores Size Cut Format QA/QC OVC228101 228 1.1mm 4um 12X19 H&E, IHC anti- Cytokeratin Recommended applications: For Research use only. RNA or protein ovary

More information

Malignant Ovarian Germ Cell Tumours: Experience in the National University Hospital of Singapore

Malignant Ovarian Germ Cell Tumours: Experience in the National University Hospital of Singapore 657 Malignant Ovarian Germ Cell Tumours: Experience in the National University Hospital of Singapore F K Lim,*MBBS, M Med, MRCOG, B Chanrachakul,**MBBS, S M Chong,***MBBS, FRCPath, FRCPA, S S Ratnam,****MD,

More information

Squamous cell carcinoma arising in a dermoid cyst of the ovary: a case series

Squamous cell carcinoma arising in a dermoid cyst of the ovary: a case series DOI: 10.1111/j.1471-0528.2007.01478.x www.blackwellpublishing.com/bjog Gynaecological oncology Squamous cell carcinoma arising in a dermoid cyst of the ovary: a case series JL Hurwitz, a A Fenton, a WG

More information

Neoplasias Quisticas del Páncreas

Neoplasias Quisticas del Páncreas SEAP -Aproximación Práctica a la Patología Gastrointestinal- Madrid, 26 de mayo, 2006 Neoplasias Quisticas del Páncreas Gregory Y. Lauwers, M.D. Director, Service Massachusetts General Hospital Harvard

More information

The Adnexal Mass. Handout NCUS 3/18/2017 Suzanne Dixon, MD

The Adnexal Mass. Handout NCUS 3/18/2017 Suzanne Dixon, MD The Adnexal Mass Handout NCUS 3/18/2017 Suzanne Dixon, MD Objectives: Pelvic mass differential Characteristics of the normal ovary Standard terminology for ovarian masses Benign vs. malignant features

More information

Human epididymal protein 4 The role of HE4 in the management of patients presenting with pelvic mass Publication abstracts

Human epididymal protein 4 The role of HE4 in the management of patients presenting with pelvic mass Publication abstracts Human epididymal protein 4 The role of HE4 in the management of patients presenting with pelvic mass Publication abstracts Ovarian cancer is diagnosed annually in more than 200,000 women worldwide, with

More information